HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard L Weiner Selected Research

N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyaniline

2/2021Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by 18F-PBR06 PET: A Clinically Feasible, Individualized Approach.
9/201818F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard L Weiner Research Topics

Disease

66Multiple Sclerosis
11/2022 - 01/2002
34Tuberous Sclerosis (Bourneville's Disease)
01/2022 - 05/2003
29Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 02/2002
26Inflammation (Inflammations)
01/2021 - 09/2002
23Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2002
20Alzheimer Disease (Alzheimer's Disease)
11/2022 - 12/2002
20Epilepsy (Aura)
01/2022 - 01/2004
17Neoplasms (Cancer)
11/2021 - 04/2002
14Seizures (Absence Seizure)
01/2021 - 01/2004
10Relapsing-Remitting Multiple Sclerosis
07/2022 - 05/2007
9Drug Resistant Epilepsy
01/2022 - 01/2004
8Infections
10/2020 - 06/2005
7Disease Progression
11/2022 - 04/2008
7Arthritis (Polyarthritis)
01/2022 - 09/2002
7Stroke (Strokes)
01/2022 - 12/2003
7Atrophy
01/2019 - 10/2014
7Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 05/2003
6Autoimmune Diseases of the Nervous System
01/2022 - 08/2005
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2022 - 06/2013
5Hypersensitivity (Allergy)
01/2022 - 08/2005
5Asthma (Bronchial Asthma)
01/2022 - 01/2002
5Atherosclerosis
01/2022 - 09/2002
5Rheumatoid Arthritis
12/2020 - 08/2005
5Neuroinflammatory Diseases
01/2018 - 09/2009
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 06/2006
5Colitis
10/2016 - 12/2002
4Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 12/2002
4Uveitis
01/2022 - 08/2005
4Infarction (Infarctions)
11/2018 - 12/2003
3Thyroiditis
01/2022 - 08/2005
3Chronic Progressive Multiple Sclerosis
02/2021 - 01/2004
3COVID-19
01/2021 - 10/2020
3Hydrocephalus (Hydrocephaly)
03/2020 - 01/2014
3Neurologic Manifestations (Neurological Manifestations)
01/2018 - 04/2014
3Hamartoma
01/2018 - 07/2008
3Glomerulonephritis
01/2018 - 05/2003
3Demyelinating Diseases (Demyelinating Disease)
12/2014 - 07/2007
3Meningoencephalitis
09/2009 - 03/2006
2Pneumonia (Pneumonitis)
01/2021 - 01/2021
2Focal Cortical Dysplasia
01/2021 - 12/2018
2Brain Neoplasms (Brain Tumor)
03/2020 - 07/2012
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 05/2017
2Gliosis
12/2018 - 01/2008
2Neuromyelitis Optica (Devic's Disease)
10/2016 - 10/2016

Drug/Important Bio-Agent (IBA)

33trans-sodium crocetinate (crocetin)IBA
01/2022 - 01/2004
16Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2008
14Monoclonal AntibodiesIBA
01/2021 - 06/2006
12Interleukin-10 (Interleukin 10)IBA
11/2017 - 09/2002
11MicroRNAs (MicroRNA)IBA
12/2019 - 07/2012
10AntigensIBA
01/2022 - 02/2002
10Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
10Peptides (Polypeptides)IBA
11/2021 - 03/2003
9InterferonsIBA
01/2020 - 08/2004
9Glatiramer Acetate (Copaxone)FDA Link
11/2018 - 02/2002
7Transforming Growth Factor beta (TGF-beta)IBA
03/2009 - 03/2003
6AutoantigensIBA
10/2016 - 09/2002
6Amyloid beta-PeptidesIBA
09/2009 - 08/2003
6Myelin-Oligodendrocyte GlycoproteinIBA
04/2008 - 05/2003
5Interferon beta-1aFDA Link
07/2022 - 11/2012
5LigandsIBA
02/2021 - 04/2002
5CytokinesIBA
12/2020 - 12/2008
5Anticonvulsants (Antiepileptic Drugs)IBA
04/2020 - 01/2004
4Biological ProductsIBA
06/2021 - 09/2010
4Alemtuzumab (Campath)FDA Link
10/2019 - 11/2012
4TOR Serine-Threonine KinasesIBA
01/2018 - 12/2013
4Fingolimod Hydrochloride (FTY720)FDA Link
12/2017 - 12/2015
4Natalizumab (Tysabri)FDA Link
05/2017 - 05/2007
4Amyloid (Amyloid Fibrils)IBA
01/2017 - 03/2006
4ChemokinesIBA
03/2008 - 05/2002
3GadoliniumIBA
01/2019 - 08/2004
3Interferon-betaIBA
11/2018 - 05/2002
3AutoantibodiesIBA
01/2018 - 11/2008
3BaclofenFDA LinkGeneric
01/2017 - 06/2005
3AntibodiesIBA
04/2016 - 03/2010
3Interleukin-17 (Interleukin 17)IBA
10/2015 - 12/2008
3GlycolipidsIBA
10/2014 - 01/2013
3OsteopontinIBA
04/2014 - 12/2008
3Interleukin-27 (Interleukin 27)IBA
12/2012 - 08/2009
3Messenger RNA (mRNA)IBA
09/2010 - 05/2005
3Myelin Basic ProteinIBA
03/2006 - 02/2002
2RNA (Ribonucleic Acid)IBA
11/2021 - 09/2012
2N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyanilineIBA
02/2021 - 09/2018
2foralumabIBA
01/2021 - 01/2021
2Pharmaceutical PreparationsIBA
01/2020 - 01/2019
2Muromonab-CD3 (Muromonab CD3)FDA Link
07/2019 - 01/2017
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2019 - 11/2010
2Retinaldehyde (Retinal)IBA
01/2018 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 09/2010
2Granzymes (Granzyme)IBA
05/2017 - 10/2016
2Therapeutic UsesIBA
01/2017 - 07/2007
2AcidsIBA
10/2016 - 11/2010
2Glia Maturation Factor (GMF)IBA
04/2016 - 10/2014
2LipidsIBA
04/2016 - 07/2012

Therapy/Procedure

38Therapeutics
01/2022 - 01/2002
10Immunotherapy
01/2022 - 05/2006
8Electrodes (Electrode)
02/2014 - 02/2005
7Oral Administration
11/2019 - 12/2003
6Transplantation
03/2016 - 06/2006
4Intranasal Administration
01/2021 - 07/2009
2Vagus Nerve Stimulation
01/2022 - 11/2009